| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |